Magic mushroom compound takes on depression in major trial
Symptom relief
Ongoing
This study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) can safely reduce depression symptoms in adults with major depressive disorder. About 238 participants will receive either 25 mg psilocybin, a low 5 mg dose, or a placebo. Researchers …
Phase: PHASE3 • Sponsor: Usona Institute • Aim: Symptom relief
Last updated May 09, 2026 04:49 UTC